Feverfew: benefits, dosage, contraindications

Mis à jour le

Feverfew is a perennial plant whose stems are branched and stiff, the leaves resemble those of the chrysanthemum and the flowers those of daisies. Feverfew is native to Asia and the Balkans but is now found in Europe, North America and North Africa, where it has adapted to all soils, even calcareous ones. Feverfew has been used for centuries as an antipyretic; the plant's common name is derived from the Latin term "febrifugia" which means "to drive away fevers." Ancient Greeks called it parthenium because legend has it it was used to save the life of a worker who fell from the Parthenon during its construction. Therapeutically, the leaves and the flowering aerial parts are used; their concentration in parthenolides is highest at the time of flowering. The leaves and flowering tops contain many monoterpenes and sesquiterpenes as well as sesquiterpene lactones (parthenolide, costulonide, chrysanthenolide...), reynosine, santamarine, tanaparthins and other compounds. Until recently, parthenolide, a sesquiterpene lactone, was thought to be the main biologically active constituent. However, this constituent does not appear to be necessary for efficacy. Other possible active agents present in feverfew include melatonin and tanetin, a lipophilic flavonoid glycoside. Monoterpenes, including alpha-pinene, camphene, limonene, gamma-terpinene, beta-ocimene, linalool, p-cymene, chrysanthenol, camphor and chrysanthenyl acetate, make up the majority of volatile substances (essential oil) emitted by the aerial parts of feverfew. Today feverfew is primarily used for the prevention of migraines and for dysmenorrhea.

Other name(s) 

Partenelle, Feverfew, Pyrethrum

Scientific name(s)

Tanacetum parthenium, Chrysanthemum parthenium, Pyrethrum parthenium

Family or group: 

Plants

Active ingredients:

Parthenolides

Melatonin

Camphor


Indications

Scoring methodology

EFSA approval.

Several randomized, double-blind, controlled clinical trials (> 2), including a significant number of patients (>100), with consistently positive conclusions for the indication.
Several randomized, double-blind, controlled clinical trials (> 2), including a significant number of patients (>100), with positive conclusions for the indication.
One or more randomized studies, or several cohorts or epidemiological studies, with positive conclusions for the indication.
Clinical studies exist but are uncontrolled, with conclusions that may be positive or conflicting.
No clinical studies to date that can demonstrate the indication.


Migraine
✪✪✪✪✪

Most clinical research shows that taking feverfew can reduce the frequency of migraines and decrease symptoms of pain, nausea, vomiting, and sensitivity to light and sound. It may be more effective in patients who have fairly frequent migraine attacks. A Cochrane systematic review of several randomized, double-blind, placebo-controlled trials concluded that the evidence was insufficient to determine whether feverfew was superior to placebo in reducing the frequency or incidence of migraines, the severity of nausea, or the severity of migraines. A closer look at the studies shows mixed results, varying methodological quality, and use of different dosing regimens, routes of administration, and extracts. These conflicting findings may reflect differences in the feverfew plants harvested or differences in the bioavailability of commercially prepared feverfew products. Dosing regimens that have shown benefit include feverfew powder 50-150 mg once daily for up to 4 months and a carbon dioxide feverfew extract (MIG-99) 2.08-18.75 mg three times daily for 3 to 4 months. ESCOP and EMA indicate the use of feverfew as a traditional medicine for the prevention of migraines.

Posologie

posologieOral: flowering tops, leaf

posologie50 mg

duration12 weeks

formulationdry extract


Synergies

Herbal medicines in migraine prevention. Randomized double-blind placebo-controlled crossover trial of a feverfew preparation
Feverfew for Preventing Migraine
European Union herbal monograph on Tanacetum parthenium (L.) Schultz Bip., herba
An observational study of fixed-dose Tanacetum parthenium nutraceutical preparation for prophylaxis of pediatric headache
Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study
Evidence-based guidelines for migraine headache (an evidence-based review)
Gelstat Migraine (sublingually administered feverfew and ginger compound) for acute treatment of migraine when administered during the mild pain phase
Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicenter, placebo-controlled study
A double-blind placebo-controlled pilot study of sublingual feverfew and ginger (LipiGesic™ M) in the treatment of migraine
Randomized double-blind placebo-controlled trial of feverfew in migraine prevention
Efficacy of Feverfew as a Prophylactic Treatment for Migraine
The Efficacy and Safety of Tanacetum Parthenium (Feverfew) in Migraine Prophylaxis--A Double-Blind, Multicenter, Randomized Placebo-Controlled Dose-Response Study
A combination of coenzyme Q10, feverfew, and magnesium for migraine prophylaxis: a prospective observational study
E/S/C/O/P: 2nd Edition of the ESCOP Monographs
The combined effect of acupuncture and Tanacetum parthenium on quality of life in women with headache: a randomized study
Tanacetum parthenium and Salix alba (Mig-RL) combination in migraine prophylaxis: a prospective, open-label study
A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial

Dysmenorrhea
✪✪✪✪

Thanks to its antispasmodic action, feverfew has traditionally been used to regulate the menstrual cycle.

Posologie

posologieBy mouth: flowering tops, leaf

posologie125 mg

formulationdry extract


Digestive spasms
✪✪✪✪

Traditionally used to combat digestive disorders (antispasmodic)

Posologie

posologieOral: flowering tops, leaf

posologie125 mg

formulationdry extract


Properties


Anti-inflammatory

full-leaffull-leaffull-leafempty-leaf

Feverfew has anti-inflammatory properties that can be explained by several mechanisms. First, it may reduce the activity of certain enzymes and substances involved in inflammation, such as proteases and leukotrienes. Next, feverfew appears to prevent the formation of prostaglandins, substances important in the inflammatory process. It acts by blocking an enzyme, phospholipase, which stops the release of a key molecule in the creation of these prostaglandins. Laboratory research has shown that some components of feverfew, such as the parthenolide, limit the production of one of these prostaglandins, PGE2. Parthenolide, in particular, targets a specific inflammation-related enzyme, COX-2, as well as various pro-inflammatory molecules. Animal studies have also shown that feverfew extracts have anti-inflammatory effects and reduce pain sensitivity, without involving opioid receptors. These effects could be due to an influence on certain molecules present in vascular cells. Although parthenolide is considered an active anti-inflammatory constituent, laboratory research suggests that feverfew depleted in parthenolide also has anti-inflammatory effects, such as inhibition of pro-inflammatory enzymes, cytokines, and prostaglandins.

Usages associés

Migraine

Neurological

full-leaffull-leafempty-leafempty-leaf

Feverfew is recognized for its potential benefits against migraine. It was once believed that parthenolide, one of its components, was essential for combating migraines, and that a concentration of at least 0.2% was necessary. However, a study with an extract containing 0.35% parthenolide did not confirm its effectiveness, suggesting that other components may be required. The mechanisms of action of feverfew in migraine prevention are not fully understood. The plant appears to affect certain enzymes and substances related to inflammation, such as proteases and leukotrienes, and to block the production of prostaglandins, which are involved in inflammation and pain. Preliminary research indicates that feverfew extracts may prevent contraction of vascular smooth muscle, a potentially beneficial effect for relieving migraines. The chrysanthenyl acetate, another substance present in the plant, is also suggested as an active component, having analgesic properties and potentially inhibiting prostaglandin formation. Feverfew also contains melatonin, which may contribute to its pharmacological effects. It should be noted that the fresh or dried leaves of the plant contain more melatonin than commercially prepared standardized tablets.

Usages associés

Migraine, Dysmenorrhea

Anticancer

full-leaffull-leafempty-leafempty-leaf

Feverfew and its constituents, particularly the parthenolide, have shown promising effects in the fight against cancer according to laboratory research. These studies suggest that feverfew could slow the growth of cancer cells and even lead them to self-destruct, a process known as apoptosis. Parthenolide, a key component of feverfew, appears to interfere with the life cycle of cancer cells, halting them or pushing them toward differentiation, then triggering their programmed death. This compound has the potential to induce apoptosis in several types of cancer cells while being non-toxic to normal cells. It also acts on certain transcription factors in cells, such as the signal transducer and activator of transcription (STAT) proteins, which are involved in cell growth, differentiation, and death. Parthenolide reduces the expression of genes that inhibit apoptosis, but this action appears to be specific to cancer cells. Furthermore, parthenolide has a different effect on cancer cells compared to normal cells with regard to reactive oxygen species (ROS). In cancer cells, it increases ROS levels, thereby promoting their death. In contrast, in non-cancerous cells, it acts as an antioxidant, reducing ROS levels. Finally, more recent research has revealed that parthenolide can trigger apoptosis in cancer cells by causing mitochondrial dysfunction. This mechanism has been shown to significantly slow tumor growth and angiogenesis, which is the formation of new blood vessels to feed the tumor, in cancer models. This proapoptotic action appears to be linked to activation of a key protein, p53, and to an increase in ROS production.


Antihistamine

full-leafempty-leafempty-leafempty-leaf

Feverfew is traditionally used for allergies. In laboratory studies on rat peritoneal mast cells, feverfew extract demonstrated a dose-dependent inhibition of histamine release.nn


Antispasmodic

full-leafempty-leafempty-leafempty-leaf

Results from several in vitro studies generally indicate that feverfew reduces vascular smooth muscle spasm.nnThis inhibition is dose- and time-dependent: this action is due to the binding of the α-methylene-butyrolactone moiety to the thiol groups of proteins.nn

Usages associés

Digestive spasms, Dysmenorrhea


Safe dosage

Adults 18 years and older: 50 mg - 120 mg (standardized extract)

- Dose of 120 mg/day of leaf extract containing 0.20% parthenolide (minimum efficacy threshold in preparations based on dried leaves) - Whole herb: 2.5 g of leaves per day with a meal; - Cryo-dried leaf: 50 mg per day with a meal; - Powder: 50-120 mg per day equivalent to 0.2-0.6 mg of parthenolide.


Interactions

Médicaments

Antiplatelet agents/Anticoagulants: moderate interaction

Feverfew can inhibit platelet activity (a component that plays a role in blood clotting), so people taking anticoagulant medications (such as aspirin and warfarin) should consult a healthcare professional before taking this herb.


Precautions

Breastfeeding women: avoid

There is not enough information on the use of feverfew as a supplement for breastfeeding women.

Children up to 2 years: avoid

The use of feverfew in children under 2 years is not recommended.

Allergies: avoid

Feverfew is not recommended for people with a known allergy to Asteraceae.

Surgical intervention: avoid

Feverfew has antiplatelet effects. It can cause excessive bleeding if used before surgery.


Contraindications

Pregnant women: contraindicated

Feverfew is contraindicated during pregnancy. Feverfew can cause uterine contractions and miscarriage.